8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of the earliest event reported): September 20, 2007

                                  Aspyra, Inc.
             (Exact Name of Registrant as Specified in Its Charter)

         California                  0-12551                  95-3353465
       (State or Other             (Commission               (IRS Employer
 Jurisdiction of Incorporation)    File Number)            Identification No.)


                               26115-A Mureau Road
                               Calabasas, CA 91302
               (Address of Principal Executive Offices) (Zip Code)

                                 (818) 880-6700
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

|_|  Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)

|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))






Item 5.02(d) Departure of Directors or Certain Officers; Election of Directors;
             Appointment of Certain Officers; Compensatory Arrangements of
             Certain Officers.

     On September 25, 2007, Aspyra, Inc. (the "Company") announced that on
September 20, 2007, the Company's Board of Directors, in accordance with Section
3.04(B) of the Company's Bylaws elected James Zierick as a member of the
Company's Board of Directors. Mr. Zierick will fill a vacancy on the Board of
Directors and will serve until the 2008 Annual Meeting of Shareholders or until
his earlier death, resignation or removal.

     James Zierick is currently the Chief Executive Officer of LOGICALAPPS, a
provider of embedded controls software for enterprise applications based in
Irvine, California. Prior to joining LOGICALAPPS, Mr. Zierick was Executive Vice
President of Worldwide Field Operations for Peregrine Systems, where he led a
350 person sales, alliance, customer support and professional services
organization. Before working with Peregrine, Mr. Zierick was a partner for
McKinsey & Company, where he helped lead the company's Southern California
technology and operational effectiveness practices. Mr. Zierick earned a Master
of Business Administration degree from the Dartmouth College, Amos Tuck School
of Business, a Bachelor of Science degree in Engineering from Dartmouth College,
Thayer School of Engineering, and a Bachelor of Arts in Engineering Sciences
from Dartmouth College.

     Upon Mr. Zierick's election as a director, the Company awarded Mr. Zierick
a non-qualified stock option under the Company's 2005 Stock Incentive Plan
exercisable for 10,000 shares of the Company's Common Stock, which is consistent
with the Company's equity compensation to its other non-employee directors.

     There are no understandings or arrangements between Mr. Zierick and any
other person pursuant to which Mr. Zierick was selected as a director. Mr.
Zierick does not have any family relationship with any director, executive
officer or person nominated or chosen by our Board of Directors to become a
director or executive officer. Additionally, there have been no transactions, or
series of related transactions, in the last year, nor is there any currently
proposed transaction, or series of similar transactions, to which the Company or
any of its subsidiaries was a party, or will be a party, and in which Mr.
Zierick or any member of his immediate family had, or will have a direct or
indirect material interest.

     A copy of the Company's press release dated September 25, 2007 is included
as Exhibit 99.1 to this report and is incorporated herein by reference.


Item 9.01  Financial Statements and Exhibits.

(d)  The following exhibits are being filed with this report:

     99.1 Press Release, dated September 25, 2007, of Aspyra, Inc.



                                   SIGNATURES


      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


September 25, 2007                             Aspyra, Inc.


                                                 /s/ Steven M. Besbeck
                                               ---------------------------------
                                                 Steven M. Besbeck
                                                 President and Chief Executive
                                                 Officer

EX-99.1

                                                                    Exhibit 99.1

               Aspyra Appoints James Zierick to Board of
                              Directors


    CALABASAS, Calif.--(BUSINESS WIRE)--Sept. 25, 2007--Aspyra, Inc.
(AMEX:APY), a leading provider of clinical and diagnostic information
solutions for the healthcare industry, today announced the appointment
of James Zierick as director to Company's Board of Directors,
effective immediately.

    With over 25 years in executive management roles in the technology
field, Mr. Zierick is currently the Chief Executive Officer of
LOGICALAPPS, a provider of embedded controls software for enterprise
applications based in Irvine, CA. Prior to joining LOGICALAPPS, Mr.
Zierick was Executive Vice President of Worldwide Field Operations for
Peregrine Systems, where he led 350 person sales, alliance, customer
support and professional services organization, and was responsible
for generating $200 million of new license, support and service
revenue. Before working with Peregrine, Mr. Zierick was a partner with
McKinsey & Company, where he helped lead the company's Southern
California technology and operational effectiveness practices,
leveraging his wide-ranging experience with major technology
companies.

    Mr. Zierick holds an MBA from Dartmouth College, Amos Tuck School
of Business and a B.S. and an A.B. from Dartmouth College, Thayer
School of Engineering.

    John Mutch, Aspyra's Chairman of the Board states, "We look
forward to Jim's contribution to the Aspyra Board of Directors. His
experience in process improvement with technology companies across a
broad variety of industries will benefit us greatly."

    Aspyra solutions provide integrated technologies and services that
improve the efficiency, safety and quality of patient care. Aspyra
works directly with customers through its own sales and service staff
as well as through an extensive partner network. The company currently
counts over 440 customers and over 700 application installations in
its installed base.

    "I am pleased to have the opportunity to work with Aspyra and
Board of Directors to help achieve success in the healthcare
technology industry," said Mr. Zierick.

    About Aspyra

    Aspyra is a global provider of Health Care Information Technology
(HCIT) solutions and services to the healthcare industry. The Company
specializes in Clinical Information Systems (CIS), Picture Archive
Communication Systems (PACS) and Clinical Image Management Systems
(CIMS) for hospitals, multi-specialty clinics, clinical laboratories,
imaging departments and centers, orthopedic environments and
pharmacies. Aspyra's highly scalable systems can be installed
standalone or integrated to provide a single-vendor, enterprise-wide
solution. For more information on Aspyra, its products and services,
visit www.aspyra.com.

    Safe Harbor Statement

    This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to corporate growth, shareholder value
creation and future business opportunities. Forward-looking statements
are not guarantees of future performance and are inherently subject to
uncertainties and other factors which could cause actual results to
differ materially from the forward-looking statement. Such statements
are based upon, among other things, assumptions made by, and
information currently available to, management as of today, September
25, 2007, including management's own knowledge and assessment of the
Company's industry and competition. Factors that could cause Aspyra's
actual results to differ materially from these forward-looking
statements include among others: the competitive environment;
unexpected technical and marketing difficulties inherent in major
product development efforts; the potential need for changes in our
long-term strategy in response to future developments; future advances
in clinical information technology and procedures, as well as
potential changes in government regulations and healthcare policies;
and rapid technological change in the microelectronics and software
industries. The Company refers interested persons to its most recent
Annual Report on Form 10-KSB and its other SEC filings for a
description of additional uncertainties and factors, which may affect
forward-looking statements. The Company assumes no duty to update its
forward-looking statements.


    CONTACT: Aspyra, Inc.
             Steven M. Besbeck, President and CEO, 818-880-6700 x8660